Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Current Leases (2019 - 2025)

Mesa Laboratories' Current Leases history spans 7 years, with the latest figure at $3.9 million for Q4 2025.

  • For Q4 2025, Current Leases rose 10.07% year-over-year to $3.9 million; the TTM value through Dec 2025 reached $3.9 million, up 10.07%, while the annual FY2025 figure was $3.5 million, 17.98% up from the prior year.
  • Current Leases for Q4 2025 was $3.9 million at Mesa Laboratories, up from $3.8 million in the prior quarter.
  • Across five years, Current Leases topped out at $3.9 million in Q4 2025 and bottomed at $2.7 million in Q4 2021.
  • The 5-year median for Current Leases is $3.5 million (2024), against an average of $3.3 million.
  • The largest annual shift saw Current Leases rose 3.61% in 2023 before it rose 27.62% in 2025.
  • A 5-year view of Current Leases shows it stood at $2.7 million in 2021, then increased by 1.28% to $2.8 million in 2022, then grew by 3.61% to $2.9 million in 2023, then grew by 23.26% to $3.5 million in 2024, then increased by 10.07% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Current Leases are $3.9 million (Q4 2025), $3.8 million (Q3 2025), and $3.8 million (Q2 2025).